Annex I

United Kingdom

Pursuant to paragraph 3 of Decision XII/2 of the Twelfth Meeting of the Parties to the Montreal Protocol on measures to facilitate the transition to chlorofluorocarbon-free metered-dose inhalers (MDIs), the following countries have determined that, due to the presence of suitable non-CFC MDIs, CFCs no longer qualify as ‘essential’ under the Protocol when combined with following active ingredients:

Table 1

Country	Short-acting Beta Agonist Bronchodilators
Source: www.unep.org/ozone/Information_for_the_Parties/3Bi_dec12-2-3.asp
Country	Salbutamol	Terbutaline	Fenoterol	Orciprenaline	Reproterol	Carbuterol	Hexoprenaline	Pirbuterol	Clenbuterol	Bitolterol	Procaterol
Austria	X	X	X	X	X	X	X	X	X	X	X
Belgium	X	X	X	X	X	X	X	X	X	X	X
Cyprus	X
Czech Republic	X	X	X	X	X	X	X	X	X	X	X
Denmark	X		X	X	X	X	X	X	X	X	X
Estonia	X	X	X	X	X	X	X	X	X	X	X
Finland	X
France	X
Germany	X	X	X	X	X	X	X	X	X	X	X
Greece	X	X	X	X	X	X	X	X	X	X	X
Hungary	X	X	X	X	X	X	X	X	X	X	X
Ireland	X
Italy	X
Latvia	X	X	X	X	X	X	X	X	X	X	X
Lithuania	X	X	X	X	X	X	X	X	X	X	X
Luxembourg	X
Malta	X
Netherlands	X	X	X	X	X	X	X	X	X	X	X
Poland	X
Portugal	X	X	X	X	X	X	X	X	X	X	X
Norway	X	X	X	X	X	X	X	X	X	X	X
Slovak Republic	X	X	X	X	X	X	X	X	X	X	X
Slovenia	X	X	X	X	X	X	X	X	X	X	X
Spain	X
Sweden	X
United Kingdom	X

Table 2

Country	Inhaled steroids
Source: www.unep.org/ozone/Information_for_the_Parties/3Bi_dec12-2-3.asp
Country	Beclomethasone	Dexamethasone	Flunisolide	Fluticasone	Budesonide	Triamcinolone
Austria
Belgium	X	X	X	X	X	X
Cyprus
Czech Republic	X	X	X	X	X	X
Denmark	X			X
Estonia	X	X	X	X	X	X
Finland	X			X
France	X			X
Germany	X	X	X	X	X	X
Greece
Hungary	X	X	X	X	X	X
Ireland	X			X
Italy	X			X	X
Latvia	X	X	X	X	X	X
Lithuania
Luxembourg
Malta				X	X
Poland
Portugal				X	X
Netherlands	X	X	X	X	X	X
Norway
Slovak Republic	X	X	X	X	X	X
Slovenia	X	X	X	X	X	X
Spain	X			X
Sweden	X	X	X	X		X
United Kingdom				X

Table 3

Country	Non-steroidal anti-inflammatories
Source: www.unep.org/ozone/Information_for_the_Parties/3Bi_dec12-2-3.asp
Country	Cromoglicic acid	Nedrocromil
Austria
Belgium	X	X
Cyprus
Czech Republic	X	X
Denmark	X	X
Estonia	X	X
Finland	X	X
France	X	X
Germany	X	X
Greece	X	X
Hungary
Ireland
Italy
Latvia	X	X
Lithuania
Luxembourg
Malta
Poland
Portugal	X
Netherlands	X	X
Norway
Slovak Republic	X	X
Slovenia	X	X
Spain		X
Sweden
United Kingdom

Table 4

Country	Anticholinergic Bronchodilators
Source: www.unep.org/ozone/Information_for_the_Parties/3Bi_dec12-2-3.asp
Country	Ipratropium bromide	Oxitropium Bromide
Austria
Belgium	X	X
Cyprus	X	X
Czech Republic	X	X
Denmark	X	X
Estonia	X	X
Finland	X	X
France
Germany	X	X
Greece	X	X
Hungary	X	X
Ireland	X	X
Italy
Latvia
Lithuania
Luxembourg
Malta	X	X
Netherlands	X	X
Poland
Portugal	X
Norway
Slovak Republic	X	X
Slovenia
Spain	X	X
Sweden	X	X
United Kingdom	X	X

Table 5

Country	Long-acting Beta Agonist Bronchodilators
Source: www.unep.org/ozone/Information_for_the_Parties/3Bi_dec12-2-3.asp
Country	Formoterol	Salmeterol
Austria
Belgium
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany	X	X
Greece
Hungary
Ireland
Italy	X
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Poland
Portugal
Norway
Slovak Republic
Slovenia
Spain
Sweden
United Kingdom

Table 6

Country	Combinations of active ingredients in a single MDI
Source: www.unep.org/ozone/Information_for_the_Parties/3Bi_dec12-2-3.asp
Austria
Belgium
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany	X
Greece
Hungary
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Poland
Portugal
Norway
Slovak Republic
Slovenia
Spain
Sweden
United Kingdom